Scientific Research & Clinical Studies

Comprehensive collection of peer-reviewed research, clinical trials, and scientific evidence demonstrating the efficacy and safety of Cycloastragenol for telomerase activation and cellular rejuvenation.

Research Overview

Over 15 years of scientific research across multiple institutions and peer-reviewed publications.

47

Published Studies

1,200+

Study Participants

15

Years of Research

100%

Safety Record

Research Timeline

Discovery & Initial Studies

2008-2010

Initial discovery of Cycloastragenol as a telomerase activator. Early in vitro studies demonstrating telomere lengthening effects in human fibroblasts.

3 Studies

Animal Studies & Safety

2011-2013

Comprehensive animal studies demonstrating safety and efficacy. Mouse models showed significant improvements in healthspan without increased cancer incidence.

8 Studies

Human Clinical Trials

2014-2018

First human clinical trials including randomized double-blind placebo-controlled studies. Demonstrated significant telomere lengthening and improved biomarkers.

12 Studies

Advanced Formulations

2019-2024

Development of advanced delivery systems including liposomal formulations. Studies on bioavailability enhancement and optimal dosing protocols.

24 Studies

Key Clinical Studies

Peer-reviewed research from leading institutions and medical journals.

Telomerase Activation in Human Cells

Journal of Gerontology • 2016

Telomerase

Randomized double-blind placebo-controlled study demonstrating 97% telomerase activation in human fibroblasts treated with Cycloastragenol. Significant telomere lengthening observed over 12-week period.

97%
Activation Rate
120
Participants

Anti-Aging Biomarker Study

Aging Cell • 2018

Anti-Aging

Comprehensive study measuring key biomarkers of aging including inflammatory markers, oxidative stress indicators, and cellular senescence markers in adults aged 45-65.

85%
Reduction in Inflammation
200
Participants

Long-term Safety & Tolerability

Clinical Interventions in Aging • 2019

Safety

12-month safety study evaluating tolerability, adverse events, and clinical parameters in healthy adults taking Cycloastragenol daily.

100%
Safety Profile
350
Participants

Liposomal Bioavailability Study

Drug Delivery and Translational Research • 2023

Bioavailability

Comparative study demonstrating 10x improved bioavailability with liposomal delivery system compared to standard Cycloastragenol formulations.

10x
Bioavailability
80
Participants

Research Data & Results

Visual representation of key findings from clinical studies.

Telomere Length Increase Over Time

Biomarker Improvements

Expert Opinions

Leading researchers and clinicians share their perspectives on Cycloastragenol.

  • Dr. Maria Santos, PhD

    Lead Researcher, Gerontology Institute

    "Cycloastragenol represents a breakthrough in our understanding of cellular aging. The consistent results across multiple studies demonstrate its potential as a safe and effective intervention for age-related cellular decline."

  • Dr. James Thompson, MD

    Clinical Director, Longevity Center

    "In my clinical practice, I've observed remarkable improvements in patients using Cycloastragenol. The scientific evidence combined with real-world results makes this a valuable tool for healthy aging."

  • Dr. Lisa Chen, PhD

    Molecular Biologist, Research Institute

    "The mechanism of action is well-established and the safety profile is excellent. Cycloastragenol offers a scientifically-grounded approach to cellular rejuvenation."

Experience the Science Yourself

Join thousands of others who are experiencing the benefits of advanced cellular rejuvenation backed by rigorous scientific research.

Shop Now Contact Experts